2/17
08:15 pm
okur
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ADAR1 Capital Management, LLC
Low
Report
Form SCHEDULE 13G OnKure Therapeutics, Filed by: ADAR1 Capital Management, LLC
2/17
04:54 pm
okur
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
Medium
Report
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: CITADEL ADVISORS LLC
2/17
04:12 pm
okur
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Medium
Report
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
1/30
02:22 pm
okur
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A OnKure Therapeutics, Filed by: VANGUARD GROUP INC
1/2
04:17 pm
okur
Form 4 OnKure Therapeutics, For: Dec 31 Filed by: Mathers Edward T
Medium
Report
Form 4 OnKure Therapeutics, For: Dec 31 Filed by: Mathers Edward T
1/2
04:10 pm
okur
Form 4 OnKure Therapeutics, For: Dec 31 Filed by: Manke Isaac
Medium
Report
Form 4 OnKure Therapeutics, For: Dec 31 Filed by: Manke Isaac
12/23
08:10 pm
okur
Form 4 OnKure Therapeutics, For: Dec 22 Filed by: Saccomano Nicholas A
Low
Report
Form 4 OnKure Therapeutics, For: Dec 22 Filed by: Saccomano Nicholas A
12/23
08:08 pm
okur
Form 4 OnKure Therapeutics, For: Dec 22 Filed by: Leverone Jason A.
Low
Report
Form 4 OnKure Therapeutics, For: Dec 22 Filed by: Leverone Jason A.